WEAK ANTIPARKINSONIAN ACTIVITY OF THE D1 AGONIST C-APB (SKF 82958) AND LACK OF SYNERGISM WITH A D2 AGONIST IN PRIMATES

被引:22
作者
RUPNIAK, NMJ
BOYCE, S
STEVENTON, M
IVERSEN, SD
机构
[1] Merck Sharp/Dohme Research Lab., Neuroscience Research Centre, Harlow, Essex CM20 2QR, Terlings Park, Eastwick Road
关键词
PARKINSONS DISEASE; DOPAMINE RECEPTORS; SQUIRREL MONKEYS; MPTP;
D O I
10.1097/00002826-199208000-00005
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The role of D1 receptors in motor control is poorly understood. In parkinsonian squirrel monkeys, the full D1 agonist C-APB (SKF 82958; 0. 1-0.4 mg/kg s.c.) caused weak stimulation of locomotor activity. However, the motor stimulant effects of the D2 agonist (+)-PHNO (0.001 mg/kg s.c.) were not potentiated by C-APB (0.3 mg/kg). Differences between these observations and expectations from experiments using rodents are discussed.
引用
收藏
页码:307 / 309
页数:3
相关论文
共 7 条
[1]   DIFFERENTIAL-EFFECTS OF D1 AND D2 AGONISTS IN MPTP-TREATED PRIMATES - FUNCTIONAL IMPLICATIONS FOR PARKINSONS-DISEASE [J].
BOYCE, S ;
RUPNIAK, NMJ ;
STEVENTON, MJ ;
IVERSEN, SD .
NEUROLOGY, 1990, 40 (06) :927-933
[2]   SELECTIVE D-1 DOPAMINE RECEPTOR AGONIST TREATMENT OF PARKINSONS-DISEASE [J].
BRAUN, A ;
FABBRINI, G ;
MOURADIAN, MM ;
SERRATI, C ;
BARONE, P ;
CHASE, TN .
JOURNAL OF NEURAL TRANSMISSION, 1987, 68 (1-2) :41-50
[3]   THE D1 AGONIST SKF-38393 INHIBITS THE ANTIPARKINSONIAN ACTIVITY OF THE D2 AGONIST LY-171555 IN THE MPTP-TREATED MARMOSET [J].
NOMOTO, M ;
JENNER, P ;
MARSDEN, CD .
NEUROSCIENCE LETTERS, 1988, 93 (2-3) :275-280
[4]   AGONIST AND ANTAGONIST PROPERTIES OF BENZAZEPINE AND THIENOPYRIDINE DERIVATIVES AT THE D1 DOPAMINE RECEPTOR [J].
OBOYLE, KM ;
GAITANOPOULOS, DE ;
BRENNER, M ;
WADDINGTON, JL .
NEUROPHARMACOLOGY, 1989, 28 (04) :401-405
[5]   EFFECTS OF CHRONIC TREATMENT OF MPTP MONKEYS WITH BROMOCRIPTINE ALONE OR IN COMBINATION WITH SKF 38393 [J].
ROUILLARD, C ;
BEDARD, PJ ;
DIPAOLO, T .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 185 (2-3) :209-215
[6]   A DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-RANGING STUDY TO INVESTIGATE THE SAFETY AND EFFICACY OF CY-208-243 IN PATIENTS WITH PARKINSONS-DISEASE [J].
TSUI, JKC ;
WOLTERS, EC ;
PEPPARD, RF ;
CALNE, DB .
NEUROLOGY, 1989, 39 (06) :856-858
[7]   BROMOCRIPTINE, SELECTIVE D2 DOPAMINE RECEPTOR AGONISTS AND D1 DOPAMINERGIC TONE [J].
WADDINGTON, JL .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1986, 7 (06) :223-224